MedPath

ANTICHOLIUM

ANTICHOLIUM solution for injection or infusion

Approved
Approval ID

b90b50e8-c8f1-4f2d-be6e-4d269b8c362c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 14, 2023

Manufacturers
FDA

Provepharm Inc.

DUNS: 086861066

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

physostigmine salicylate

PRODUCT DETAILS

NDC Product Code81284-831
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationINTRAVENOUS
Effective DateSeptember 14, 2023
Generic Namephysostigmine salicylate

INGREDIENTS (5)

EDETATE SODIUMInactive
Code: MP1J8420LU
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PHYSOSTIGMINE SALICYLATEActive
Quantity: 0.4 mg in 1 mL
Code: 2046ZRO9VU
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ANTICHOLIUM - FDA Drug Approval Details